Elevated activity of RNA A-to-I editing is observed in various cancer types and is associated with poor prognosis, and systematic exploration of cancer vulnerabilities informs the dependency of ADAR1 in a subset of cancer cells50–52. This evidence concerns the gene ADAR and cancer.